| abstract |
The present invention relates to an oral pharmaceutical composition for use in the treatment of irritable bowel syndrome, diarrhea, constipation, abdominal pain and / or flatulence, which comprises i) capsaicin or resiniferatoxin, pharmaceutically acceptable salts, analogs and / or derivatives thereof; and ii) as component b) a pharmaceutically acceptable carrier, wherein the pharmaceutical composition comprises a dosage unit form having an osmotic dissolution or an enteric coating from which component a) is dissolved in the gastrointestinal tract and component b) allows component a) dissolution in the digestive tract of the stomach and rectum. HE |